NASDAQ$MODVQ
Modivcare Inc · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Briefing
ModivCare reported Q1 2025, revenue of $142M, net loss of $43.3M.
For Q1 2025, ModivCare reported revenue of $142M, a net loss of $43.3M. Management discusses operating trends, capital, and sector risks in the quarterly filing.
- Q1 2025 revenue $142M.
- Net loss $43.3M.
- ModivCare highlights liquidity, execution, and sector-specific risks in MD&A.
Headline financials
Revenue & EPS history
Modivcare · Revenue · Quarterly
$651M
Forward guidance
Life-sciences filers emphasize pipeline milestones, regulatory paths, and cash runway; product revenue is limited or emerging.
Tailwinds
- Pipeline progress and partnership optionality.
- Cash balances funding operations into upcoming catalysts.
- Commercial launches where approved.
Headwinds
- Trial failure or regulatory delay risk.
- Dilution from equity raises.
- Reimbursement and competitive pressure.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 6 quarterly earnings reports · overlaid with Q1 2025
+0.1%
Avg return
Earnings day
-10.6%
Avg return
5 days after
+29.9%
Avg return
30 days after
53%
33 / 62 earnings
Positive
+21.0%
Q1 2024
Best reaction
-41.0%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | — | — | — | |
| Q1 2025 | -11.4% | -26.5% | +198.5% | |
| Q4 2024 | -22.5% | -35.9% | -68.1% | |
| Q3 2024 | +10.6% | -0.7% | +11.3% | |
| Q2 2024 | +15.8% | +18.8% | +59.8% | |
| Q1 2024 | +21.0% | +18.5% | +23.0% | |
| Q4 2023 | -41.0% | -37.7% | -44.9% | |
| Q3 2023 | +14.5% | — | — | |
| Q2 2023 | -4.4% | — | — | |
| Q1 2023 | -21.6% | — | — | |
| Q4 2022 | -1.6% | — | — | |
| Q3 2022 | -5.9% | — | — | |
| Q2 2022 | +2.0% | — | — | |
| Q1 2022 | -7.2% | — | — | |
| Q4 2021 | +16.5% | — | — | |
| Q3 2021 | -8.8% | — | — | |
| Q2 2021 | -1.2% | — | — | |
| Q1 2021 | +2.0% | — | — | |
| Q4 2020 | -15.4% | — | — | |
| Q3 2020 | +4.1% | — | — | |
| Q2 2020 | +8.8% | — | — | |
| Q1 2020 | +7.9% | — | — | |
| Q4 2019 | -9.2% | — | — | |
| Q3 2019 | +5.2% | — | — | |
| Q2 2019 | +2.6% | — | — | |
| Q1 2019 | +2.3% | — | — | |
| Q4 2018 | +0.1% | — | — | |
| Q3 2018 | +11.4% | — | — | |
| Q2 2018 | -9.3% | — | — | |
| Q1 2018 | -6.3% | — | — | |
| Q4 2017 | +7.6% | — | — | |
| Q3 2017 | +5.2% | — | — | |
| Q2 2017 | +0.0% | — | — | |
| Q1 2017 | +10.3% | — | — | |
| Q4 2016 | +8.8% | — | — | |
| Q3 2016 | -7.0% | — | — | |
| Q2 2016 | -1.7% | — | — | |
| Q1 2016 | -0.8% | — | — | |
| Q4 2015 | +16.3% | — | — | |
| Q3 2015 | -14.6% | — | — | |
| Q2 2015 | -0.8% | — | — | |
| Q1 2015 | +12.2% | — | — | |
| Q4 2014 | +9.9% | — | — | |
| Q3 2014 | -11.3% | — | — | |
| Q2 2014 | +17.8% | — | — | |
| Q1 2014 | -2.7% | — | — | |
| Q4 2013 | -10.4% | — | — | |
| Q3 2013 | -11.7% | — | — | |
| Q2 2013 | +0.7% | — | — | |
| Q1 2013 | +6.7% | — | — | |
| Q4 2012 | +5.1% | — | — | |
| Q3 2012 | +16.4% | — | — | |
| Q2 2012 | -14.7% | — | — | |
| Q1 2011 | -0.9% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -2.2% | — | — | |
| Q4 2011 | -2.2% | — | — | |
| Q3 2010 | -2.3% | — | — | |
| Q3 2011 | -2.3% | — | — | |
| Q2 2011 | +4.3% | — | — | |
| Q2 2010 | +4.3% | — | — | |
| Q4 2010 | +4.3% | — | — | |
| Q1 2010 | +1.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro